Addex to Present at the Swiss Biotech Day 2024

Geneva, Switzerland, April 19, 2024 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that CEO, Tim Dyer, will...

Related Keywords

Switzerland ,United States ,Geneva ,Genè ,American ,Swiss ,Mike Sinclair ,Tim Dyer ,Janssen Pharmaceuticals Inc ,Congress Center ,Swiss Exchange ,Nasdaq ,Swiss Biotech Day ,Addex Therapeutics ,Janssen Pharmaceuticals ,American Depositary Shares ,Executive Officer ,Halsin Partners ,Forward Looking Statements ,Private Securities Litigation Reform Act ,Addex Therapeutic Annual Report ,Addex Therapeutic ,Markets ,